1. Home
  2. TCRT vs JTAI Comparison

TCRT vs JTAI Comparison

Compare TCRT & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

N/A

Current Price

$1.57

Market Cap

7.8M

Sector

Health Care

ML Signal

N/A

JTAI

Jet.AI Inc.

N/A

Current Price

$0.91

Market Cap

8.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TCRT
JTAI
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
8.1M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
TCRT
JTAI
Price
$1.57
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 4.5M
61.2K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
24.66
★ 100.69
EPS
★ N/A
N/A
Revenue
★ $15,900,000.00
$9,177,767.00
Revenue This Year
N/A
$0.26
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.72
$0.80
52 Week High
$4.50
$2,082.00

Technical Indicators

Market Signals
Indicator
TCRT
JTAI
Relative Strength Index (RSI) 45.54 36.87
Support Level $1.02 $0.80
Resistance Level $1.96 $1.09
Average True Range (ATR) 0.20 0.10
MACD -0.08 0.01
Stochastic Oscillator 13.60 27.59

Price Performance

Historical Comparison
TCRT
JTAI

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of fractional and whole interests in aircraft, the sale of jet cards, which enable holders to use certain of the company's and other's aircraft at agreed-upon rates, the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third-party carriers as well as via the company's leased and managed aircraft, direct chartering of its HondaJet Elite aircraft by Cirrus Aviation Services, aircraft brokerage and monthly management and hourly operation of customer aircraft. It also offers the SaaS software to aircraft owners and operators generally: Reroute AI; and DynoFlight. The company operates in a single operating and reportable segment which is private aviation services.

Share on Social Networks: